Delivering lasting change in oncology, improved partner performance and better patient outcomes.
Patient Satisfaction (NPS)
Patients are likely to recommend our platform. At 28, we’re showing a strong and above average* healthcare NPS score.
Reduced Resolution Times
Clinics using our platform respond more quickly to patient issues and regularly see a 30%+ improvement in incident resolution times.
Reductions in ED Visits and Hospitalizations
Reduced unnecessary ED visits and hospitalizations by 8% through improvements in remote symptom management.
Increased Medication Adherence
Clinics & life sciences partners have seen a 16% increase in time on therapy through timely & proactive digital interventions and patient education.
Genentech and Navigating Cancer researchers analyzed data from more than 200K people living with cancer, found that most communities of color have limited access and online communication with oncologists on digital health platforms.
In a study of real-world ePRO implementation, Texas Oncology targeted cancer patients initiating systemic therapy to enroll in the Health Tracker ePRO digital monitoring program. The process included patient screening, introduction to the program, enrollment, initiation, observation, and intervention through the triage board workflow. There was a 65% ePRO compliance rate in the 4375 patients enrolled, as well as high participation rates among patients 65 years and older, those completing ePROs via text message, and patients on oral treatment.
Duke and Navigating Cancer researchers aimed to describe sociodemographic correlates of patient-reported pain among H&N cancer patients receiving care in the community setting. The study found one-in-six HNC patients in the community oncology setting reported pain, and while there were no racial differences in any pain report, white patients were significantly more likely to receive new pain prescriptions, as were those with Medicare or commercial insurance.